POSC257 Radiopharmaceutical Treatments and HTA: The Case of [177lu]-DOTATATE

E Garagiola, LB Ferrario,O Bagni,CM Grana, S Lastoria, RE Pellerito,M Salgarello, E Seregni,S Severi,G Storto,A Versari, E Foglia

Value in Health（2022）

引用 0|浏览13

暂无评分

摘要

The study aims to define the benefits concerning radiopharmaceutical treatment introduction of [177Lu]-DOTATATE, for patients affected by gastroenteropancreatic neuroendocrine tumors, approaching with a Health Technology Assessment.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要